|
Abstract
【Abstract】 Objective Our goal was to investigate the relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and the insulin sensitivity in healthy newborns. Method One hundred eighty healthy newborns, all of whom had a 1-minute Apgar score of >7 and gestational age >33 weeks, were enrolled in the study. Fasting glucose and insulin levels were measured on day 2 or 3 after birth, and angiotensin-converting enzyme genotype was determined.Result The observed frequency distribution of angiotensin
converting enzyme genotypes did not deviate from that predicted by Hardy-Weinberg equilibrium in this group. There were no statistically significant differences in birth size and shape in different angiotensinconverting
enzyme genotypes. Those carriers of the genotype homozygous for the deletion allele had the highest
logarithmically transformed homeostasis model assessment (HOMA) compared with those who were heterozygous
or homozygous for the insertion polymorphism. When compared with those with ≥1 insertion allele, those of
the genotype homozygous for the deletion allele had significantly higher logarithmically transformed fasting
insulin and logarithmically transformed homeostasis model assessment . results Regarding birth weight, birth
length, ponderal index, and fasting glucose concentration, there were no significant differences between the
genotype homozygous for the deletion allele and the genotypes heterozygous or homozygous for the insertion
allele. Conclusion In this study, the deletion allele was associated with relatively impaired insulin sensitivity in healthy neonates. It may be a clue to explain the association between the deletion allele and insulin resistance
in the long-term.
|
2014, Vol. 2 
